Geographic distribution and coverage of pediatric ophthalmologists in the United States

Jovany J Franco1, Jeremy N Shapiro2, Mikaelah A Johnson-Griggs2

  • 1Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor.

Insights

A shortage of pediatric ophthalmologists (POs) affects US children. Many kids lack access to timely eye care, with 1 in 7 living over an hour away from a specialist.

Area of Science:

  • Ophthalmology
  • Health Services Research
  • Geographic Information Systems

Background:

  • The United States experiences a significant shortage of pediatric ophthalmologists (POs).
  • Understanding the geographic distribution and accessibility of POs is crucial for policy and care improvement.
  • Current data on PO service areas is limited.

Purpose of the Study:

  • To analyze the geographic coverage and accessibility of pediatric ophthalmologist services across the United States.
  • To identify populations with limited access to pediatric eye care specialists.
  • To inform strategies for improving pediatric eye care delivery and policy.

Main Methods:

  • Utilized drive time-based service area analysis to map the reach of pediatric ophthalmologists.
  • Assessed the geographic distribution of POs relative to the pediatric population.
  • Correlated access to care with demographic variables.

Main Results:

  • Approximately 1 in 7 American children reside more than 60 minutes away from a pediatric ophthalmologist.
  • Geographic access to POs varies significantly across different regions and demographic groups.
  • Reduced access was linked to specific demographic factors, highlighting disparities in care.

Conclusions:

  • Significant geographic barriers limit access to pediatric eye care for a substantial portion of US children.
  • Targeted interventions are needed to address disparities in PO distribution and improve access.
  • Findings support the need for policy changes and enhanced recruitment for pediatric ophthalmology training programs.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...